Trial of Solanezumab in Preclinical Alzheimer's Disease
Eli Lilly and Company
Reisa A Sperling; Michael C Donohue; Rema Raman; Michael S Rafii; Keith Johnson; Colin L Masters; Christopher H van Dyck; Takeshi Iwatsubo; Gad A Marshall; Roy Yaari; Michele Mancini; Karen C Holdridge; Michael Case; John R Sims; Paul S Aisen; A4 Study Team